Towards Preanalytical Best Practices for Liquid Biopsy Studies: A BLOODPAC Landscape Analysis

The Blood Profiling Atlas in Cancer Consortium (BLOODPAC) has published a new white paper, “Towards Preanalytical Best Practices for Liquid Biopsy Studies: A BLOODPAC Landscape Analysis,” in the August issue of Clinical Pharmacology & Therapeutics.

BLOODPAC previously recommended 11 preanalytical minimal technical data elements (MTDEs) for BLOODPAC-sponsored studies and data submitted to BLOODPAC Data Commons. The current landscape analysis evaluates the overlap of the BLOODPAC MTDEs with current best practices, guidelines, and standards documents related to clinical and research liquid biopsy applications. The authors found a high degree of concordance among these documents providing further support for the validity of these data elements.

Click here for the full article.

Previous
Previous

Lexicon for blood-based early detection and screening: BLOODPAC consensus document

Next
Next

Recommendations for the Equitable and Widespread Implementation of Liquid Biopsy for Cancer Care